Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

SSA: JSFC Sistema: Sistema’s Binnopharm and Alium Group of Companies Combine Assets

  SSA: JSFC Sistema: Sistema’s Binnopharm and Alium Group of Companies Combine

UK Regulatory Announcement



                                COMBINE ASSETS

Moscow, Russia – April 02, 2013 – Sistema JSFC (“Sistema”) (LSE: SSA), the
largest publicly-traded diversified holding company in Russia and the CIS,
today announces that its subsidiary CJSC Binnopharm (“Binnopharm”) and Alium
Group of Companies (“Alium”), a producer of infusion solutions and blood
substitutes, have completed a deal that combines their assets. The deal was
structured as an additional share issuance, with Sistema participating cash
and Zenitko Finance Management LLC with Alium’s assets. The combined entity
will operate under the Binnopharm name.

After combining Binnopharm’s and Alium’s assets, Binnopharm represents a group
consisting of two large production complexes that meet high European standards
in pharmaceutical production and several distribution companies.

The additional share issuance totalled approximately RUB 1.749 billion. As a
result of the deal, Sistema has decreased its shareholding in Binnopharm from
100% to 74%. Zenitko Finance Management LLC holds a 26% stake in Binnopharm.

Mikhail Shamolin, the President and Chief Executive Officer of Sistema,
commented: “The combination of Binnopharm’s and Alium’s assets into Binnopharm
will enable the integrated company to expand its business by entering new
segments which cover the medicine in most demand. As well as enhancing the
production capacity, the deal will help to strengthen the company’s management
team and its distribution network, and it will reduce commercial and G&A
expenses. Going forward, as part of the internal reorganisation of Binnopharm,
we plan to simplify its ownership structure, optimize its cost structure and
increase transparency at the company.”


For further information, please visit or contact:

Investor Relations        Public Relations

Evgeniy Chuikov           VsevolodSementsov
Tel.: +7 (495) 692 1100   Tel.:+7 (495) 730 1705   

Sistema is the largest publicly-traded diversified holding company in Russia
and the CIS, which invests in and is a major shareholder of companies serving
over 100 million customers in the sectors of telecommunications, high
technology, oil and energy, radars and aerospace, banking, retail, mass-media,
tourism and healthcare services. Founded in 1993, the company reported
revenues of US$ 8.8 billion for the third quarter of 2012, and total assets of
US$ 46.3 billion as at September 30, 2012. Sistema’s global depository
receipts are listed under the symbol “SSA” on the London Stock Exchange.
Sistema’s ordinary shares are listed under the symbol “AFKS” on the MICEX-RTS
Stock Exchange, and under the symbol “SIST” on the Moscow Stock Exchange
(MSE). Sistema was ranked number 315 in the 2011 edition of the Fortune Global
500 list. Website:

The Company is not an investment company, and is not and will not be
registered as such, under the U.S. Investment Company Act of 1940.

Some of the information in this press release may contain projections or other
forward-looking statements regarding future events or the future financial
performance of Sistema. You can identify forward looking statements by terms
such as “expect,” “believe,” “anticipate,” “estimate,” “intend,” “will,”
“could,” “may” or “might” the negative of such terms or other similar
expressions. We wish to caution you that these statements are only predictions
and that actual events or results may differ materially. We do not intend to
update these statements to reflect events and circumstances occurring after
the date hereof or to reflect the occurrence of unanticipated events. Many
factors could cause the actual results to differ materially from those
contained in our projections or forward-looking statements, including, among
others, general economic conditions, our competitive environment, risks
associated with operating in Russia, rapid technological and market change in
our industries, as well as many other risks specifically related to Sistema
and its operations.

This document does not constitute or form part of any offer or invitation to
sell or issue, or any solicitation of any offer to purchase or subscribe for,
any shares or other securities of JSFC Sistema and/or any of its subsidiaries
and affiliated companies, nor shall any part of it nor the fact of its
distribution form part of or be relied on in connection with any contract or
investment decision relating thereto, nor does it constitute a recommendation
regarding the shares or securities of JSFC Sistema and/or any of its
subsidiaries and affiliated companies.


JSFC Sistema
Sponsored Links
Sponsored Links